Analysts expect A. Schulman, Inc. (NASDAQ:SHLM) to report $0.65 EPS on June, 27.They anticipate $0.02 EPS change or 3.17% from last quarter’s $0.63 EPS. SHLM’s profit would be $19.17M giving it 17.02 P/E if the $0.65 EPS is correct. After having $-0.11 EPS previously, A. Schulman, Inc.’s analysts see -690.91% EPS growth. The stock decreased 0.45% or $0.2 during the last trading session, reaching $44.25. About 155,272 shares traded. A. Schulman, Inc. (NASDAQ:SHLM) has risen 50.77% since June 14, 2017 and is uptrending. It has outperformed by 38.20% the S&P500. Some Historical SHLM News: ; 09/04/2018 – A. Schulman Highlights Product Innovations and Material Expertise at NPE 2018; 22/05/2018 – LyondellBasell Acquiring A. Schulman for a Total Consideration of $2.25B; 21/03/2018 – LyondellBasell Acquisition of A. Schulman Expected to Close in Second Half of 2018; 11/04/2018 – A. Schulman Supports Customer Success at Chinaplas 2018; 11/05/2018 – Alpine Associates Buys New 1.7% Position in A Schulman; 21/03/2018 – FTC Grants Early Termination of Antitrust Waiting Period for LyondellBasell Acquisition of A. Schulma; 28/03/2018 – A Schulman: In Light of Pending Merger, the Co Has Suspended Its Fiscal 2018 Guidance; 15/03/2018 – CORRECTED-UPDATE 3-LyondellBasell doubles plastics business with $2.25 bln Schulman deal (Feb. 15); 13/03/2018 Lifshitz & Miller LLP Announces Investigation of A. Schulman, Inc., CSRA Inc., Infinity Property and Casualty Corporation, Layn; 28/03/2018 – A SCHULMAN INC – IN LIGHT OF PENDING MERGER, COMPANY HAS SUSPENDED ITS FISCAL 2018 GUIDANCE
Cibc World Markets Inc increased Glaxosmithkline Plc (GSK) stake by 200.32% reported in 2018Q1 SEC filing. Cibc World Markets Inc acquired 321,860 shares as Glaxosmithkline Plc (GSK)’s stock rose 7.70%. The Cibc World Markets Inc holds 482,529 shares with $18.85 million value, up from 160,669 last quarter. Glaxosmithkline Plc now has $101.59 billion valuation. The stock decreased 0.15% or $0.06 during the last trading session, reaching $41.14. About 1.83 million shares traded. GlaxoSmithKline plc (NYSE:GSK) has declined 6.39% since June 14, 2017 and is downtrending. It has underperformed by 18.96% the S&P500. Some Historical GSK News: ; 23/03/2018 – GlaxoSmithKline pulls out of $20 billion race for Pfizer’s consumer health-care business; 25/04/2018 – GSK rules out entering Shire takeover battle; 12/04/2018 – GLAXOSMITHKLINE PLC – GSK TAKES 19.9% EQUITY STAKE IN ORCHARD AND SEAT ON BOARD; 24/04/2018 – GSK,INNOVIVA: FDA OKS EXPANDED INDICATION FOR TRELEGY ELLIPTA; 27/03/2018 – CNBC Wires: Nestle, other food groups likely suitors for GSK’s Horlicks; 23/03/2018 – GlaxoSmithKline Withdraws From Pfizer’s Consumer Healthcare Business Sale; 20/03/2018 – GSK SEES COMPLETION OF STUDY IN 2021; 09/03/2018 – GSK NIGERIA APPOINTS BHUSHAN AKSHIKAR AS MANAGING DIRECTOR; 22/03/2018 – GSK leads race to […]; 25/04/2018 – GLAXOSMITHKLINE PLC GSK.L – SHINGRIX SALES OF £110 MLN
Among 9 analysts covering Schulman A (NASDAQ:SHLM), 2 have Buy rating, 0 Sell and 7 Hold. Therefore 22% are positive. Schulman A had 23 analyst reports since August 13, 2015 according to SRatingsIntel. The company was upgraded on Wednesday, January 6 by Longbow. Northcoast upgraded A. Schulman, Inc. (NASDAQ:SHLM) on Friday, August 26 to “Buy” rating. The stock has “Hold” rating by Gabelli on Friday, February 16. The company was maintained on Wednesday, January 10 by Seaport Global. The firm earned “Hold” rating on Monday, August 15 by Gabelli. On Tuesday, October 4 the stock rating was upgraded by Gabelli to “Buy”. The firm has “Accumulate” rating by Global Hunter Securities given on Thursday, August 13. Longbow downgraded the shares of SHLM in report on Friday, February 16 to “Neutral” rating. On Thursday, March 29 the stock rating was maintained by Seaport Global with “Hold”. The firm has “Sector Weight” rating given on Monday, March 14 by KeyBanc Capital Markets.
Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.26, from 1.14 in 2017Q4. It dived, as 35 investors sold A. Schulman, Inc. shares while 50 reduced holdings. 36 funds opened positions while 39 raised stakes. 22.94 million shares or 3.42% more from 22.18 million shares in 2017Q4 were reported. Aqr Capital Management Ltd Company reported 18,116 shares. The Ohio-based Pub Employees Retirement Systems Of Ohio has invested 0% in A. Schulman, Inc. (NASDAQ:SHLM). Ghp Inv Advsr accumulated 38,153 shares or 0.23% of the stock. Indexiq Ltd Limited Liability Company has 0.18% invested in A. Schulman, Inc. (NASDAQ:SHLM). D E Shaw And reported 5,039 shares. Pointstate Limited Partnership owns 58,300 shares. Glenmede Na holds 2,610 shares or 0% of its portfolio. Moreover, Strs Ohio has 0% invested in A. Schulman, Inc. (NASDAQ:SHLM) for 22,400 shares. Guggenheim Capital Ltd Com invested 0% of its portfolio in A. Schulman, Inc. (NASDAQ:SHLM). New York-based Stone Ridge Asset Management Ltd Liability Com has invested 0.02% in A. Schulman, Inc. (NASDAQ:SHLM). Dubuque Comml Bank And Trust has 0.05% invested in A. Schulman, Inc. (NASDAQ:SHLM). Swiss State Bank reported 51,700 shares or 0% of all its holdings. United Kingdom-based Marshall Wace Llp has invested 0.11% in A. Schulman, Inc. (NASDAQ:SHLM). Rhumbline Advisers holds 71,208 shares or 0.01% of its portfolio. Eqis Cap Incorporated reported 17,621 shares.
More news for A. Schulman, Inc. (NASDAQ:SHLM) were recently published by: Globenewswire.com, which released: “Report: Developing Opportunities within Rush Enterprises, Patrick Industries, A. Schulman, Pareteum, Workiva, and …” on May 22, 2018. Streetinsider.com‘s article titled: “LyondellBasell Industries (LYB) Granted Chinese Antitrust Clearance for Acquisition of A. Schulman (SHLM)” and published on May 22, 2018 is yet another important article.
A. Schulman, Inc. manufactures and supplies plastic compounds and resins. The company has market cap of $1.31 billion. It offers custom performance colors, including standard and customized colors, organic and inorganic pigments, high chroma colors in translucent or opaque formats, and special effects. It has a 34.87 P/E ratio. The firm also provides engineered composites, such as thermoset bulk, sheet, and thick molding compounds, as well as high performance engineered structural composite solutions for original equipment manufacturers and custom molders.
Cibc World Markets Inc decreased Snap On Inc (NYSE:SNA) stake by 3,249 shares to 2,637 valued at $389,000 in 2018Q1. It also reduced Mosaic Co New (NYSE:MOS) stake by 13,211 shares and now owns 50,866 shares. Biogen Inc (NASDAQ:BIIB) was reduced too.